It was further shown that the suppressed SLC7A11 expression results in decreased cystine uptake and GSH biosynthesis in ARID1A-deficient cancer cells, which induces a vulnerability rendering ARID1A-deficient cancers susceptible for pharmacological inhibition of GSH biosynthesis (Ogiwara et al., 2019). The gene discussed is ARID1A; the disease is cancer.